Mosley Wealth Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
MWM
GAM
SIAP
SOS
NAM
DC
PFS
Mosley Wealth Management's SBIO Position: Q2 2026 in Review
Mosley Wealth Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2026, closing a stake of 37 shares — an estimated $1.44K sold.
Mosley Wealth Management first reported a position in SBIO in Q1 2026 and held it in 1 quarter. The position peaked at $1.44K in Q1 2026. 33 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.
- Mosley Wealth Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2026 after selling out during the quarter.
- Mosley Wealth Management sold 37 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $1.44K.
- Mosley Wealth Management first reported a position in ALPS Medical Breakthroughs ETF in Q1 2026 and held it in 1 quarter.
- Mosley Wealth Management's ALPS Medical Breakthroughs ETF position peaked at $1.44K in Q1 2026.
- 33 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.
Based on Mosley Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.